Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Akenroye AT, Segal JB, Zhou G, Foer D, et al. COMPARATIVE EFFECTIVENESS OF OMALIZUMAB, MEPOLIZUMAB, AND DUPILUMAB IN ASTHMA: A TARGET TRIAL EMULATION. J Allergy Clin Immunol 2023 Feb 3:S0091-6749(23)00144.
PMID: 36740144


Privacy Policy